Latest news
BioCryst Bets On Rare Genetic Disorder Therapy Expansion Amid Q2 Earnings Beat – Retail Piles On Buyout Speculation - StocktwitsStocktwits · Fri, 07 Aug 2026 07:46:45 GMTAstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’ - TradingViewTradingView · Wed, 05 Aug 2026 16:17:11 GMT